‼️ Finally, our post-hoc analysis of the COVACTA trial #COVID19 is out:
--> We showed that the probability of death or UCI stay at day 28 was lower in those with lower Anti-S Ab and treated with tocilizumab vs the same serostatus and placebo
#BMCInfectiousDiseases #IDtwitter
--> We showed that the probability of death or UCI stay at day 28 was lower in those with lower Anti-S Ab and treated with tocilizumab vs the same serostatus and placebo
#BMCInfectiousDiseases #IDtwitter
May 8, 2025 at 7:18 PM
‼️ Finally, our post-hoc analysis of the COVACTA trial #COVID19 is out:
--> We showed that the probability of death or UCI stay at day 28 was lower in those with lower Anti-S Ab and treated with tocilizumab vs the same serostatus and placebo
#BMCInfectiousDiseases #IDtwitter
--> We showed that the probability of death or UCI stay at day 28 was lower in those with lower Anti-S Ab and treated with tocilizumab vs the same serostatus and placebo
#BMCInfectiousDiseases #IDtwitter
All opportunities to develop and share robust evidence to help us enhance progress towards #elimination of viral #hepatitis should be welcomed! Note special issue of #BMCInfectiousDiseases planned for 2026.
#HepSky #MedSky #GastroSky #IDSky 🧪
#HepSky #MedSky #GastroSky #IDSky 🧪
CALL FOR PAPERS
BMC Infectious Diseases – Special Collection
Hepatitis Virus Infections and Treatment
Guest Editors: Dr Sofia Bartlett & Dr Isaac Thom Shawa
Now accepting submissions.
🗓️ Deadline: 30 June 2026
🔗 Submit here: www.biomedcentral.com/collections/...
BMC Infectious Diseases – Special Collection
Hepatitis Virus Infections and Treatment
Guest Editors: Dr Sofia Bartlett & Dr Isaac Thom Shawa
Now accepting submissions.
🗓️ Deadline: 30 June 2026
🔗 Submit here: www.biomedcentral.com/collections/...
Call for papers - Hepatitis virus infections and treatment
www.biomedcentral.com
October 22, 2025 at 6:23 AM
All opportunities to develop and share robust evidence to help us enhance progress towards #elimination of viral #hepatitis should be welcomed! Note special issue of #BMCInfectiousDiseases planned for 2026.
#HepSky #MedSky #GastroSky #IDSky 🧪
#HepSky #MedSky #GastroSky #IDSky 🧪